Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan

Kazuki Takano1 Division of Infectious Diseases and Infection Control;2 Laboratory for Clinical Microbiology, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi, Japan

Yuji Watanabe1 Division of Infectious Diseases and Infection Control;2 Laboratory for Clinical Microbiology, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi, Japan

https://orcid.org/0000-0002-1021-3769

Maya Hariu1 Division of Infectious Diseases and Infection Control;2 Laboratory for Clinical Microbiology, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi, Japan

Masafumi Seki1 Division of Infectious Diseases and Infection ControlCorrespondence[email protected]

https://orcid.org/0000-0001-5414-8148

References

Seki M. Trends in the management of infectious disease under SARS-CoV-2 era: from pathophysiological comparison of COVID-19 and influenza. World J Virol. 2021;10:62–68. doi:10.5501/wjv.v10.i2.6233816151
PubMedGoogle Scholar
Kuzmina A, Khalaila Y, Voloshin O, et al. SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera. Cell Host Microbe. 2021;29:522–528. doi:10.1016/j.chom.2021.03.00833789085
PubMed Web of Science ®Google Scholar
Rambaut A, Loman N, Pybus O, et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. ARTIC Network 2020; Available from: https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563. Accessed 626, 2021.
Google Scholar
Lubinski B, Tang T, Daniel S, Jaimes JA, Whittaker GR. Functional evaluation of proteolytic activation for the SARS-CoV-2 variant B.1.1.7: role of the P681H mutation. bioRxiv. 2021. doi:10.1101/2021.04.06.438731.
Google Scholar
Kemp SA, Collier DA, Datir RP, et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592:277–282. doi:10.1038/s41586-021-03291-y33545711
PubMed Web of Science ®Google Scholar
Hirotsu Y, Omata M. Discovery of a SARS-CoV-2 variant 1 from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan. J Infect. 2021. doi:10.1016/j.jinf.2021.03.013.
Web of Science ®Google Scholar

Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date